China Anticipates Speeding Up R&D By Joining OECD As Observer - DIA China Conference
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's status as an observer country in the Organization for Economic Cooperation and Development will help the local contract research organization sector get faster access to the world's top biomedical markets for drugs developed and tested in China, said leaders at DIA's China conference May 19